An interventional study of Oat-Based porridge and Calcium & Vitamin D3 supplementation in Hypocalcemia and Pregnancy Complications Affecting Fetus (Diagnosis), sponsored by University of Lahore Hospital (ULH). Completed at 1 site in Pakistan. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by University of Lahore Hospital (ULH) · Not applicable, Interventional, and Treatment
This study evaluates the therapeutic effects of an oat-based porridge composite on fetomaternal outcomes and calcium/ vitamin D status among hypocalcemic antenatal women. Pregnant women diagnosed with hypocalcemia are evaluated to determine the efficacy of composite cereal supplementation alongside standard medical care. Blood samples collected at the 8th and 33rd weeks of gestation are analyzed to assess changes in serum calcium and Vitamin D concentrations. The study aims to evaluate whether oat-based porridge supplementation provides beneficial nutritional support for managing hypocalcemia during pregnancy.
Pregnant women diagnosed with hypocalcemia are enrolled and allocated into two primary study groups: a control group (T0) receiving standard clinical care (calcium and Vitamin D supplementation as prescribed by attending physicians) and an interventional group(Ta) receiving an optimized oat-based composite porridge formulation in combination with standard supplementation.
The composite oat-based porridge formulations (composed of oats, chickpeas, almonds, chia seeds, and sorghum) are designed to improve maternal mineral adequacy. Maternal blood samples are drawn at baseline (8th week of gestation) and follow-up (33rd week of gestation) to measure changes in serum calcium (mg/dL) and Vitamin D (ng/mL) concentrations, as well as to assess related fetomaternal health parameters from baseline to delivery.
98 studies on the registry are indexed under Hypocalcemia; 16 are open to participants now.
This study's enrollment of 192 is above the median of 84 across 66 interventional studies indexed under Hypocalcemia.
Browse Hypocalcemia studies →University of Lahore Hospital (ULH) is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receiving standard supplementation of calcium and vit.D
Dietary Supplement: Calcium & Vitamin D3 supplementation
Participants receiving standard supplementation of calcium and vit.D along with interventional Oat-Based Porridge
Dietary Supplement: Oat-Based porridge · Dietary Supplement: Calcium & Vitamin D3 supplementation
participants consumed Oat-based porridge daily as part of their diet during pregnancy alongside standard prenatal supplements
standard prescribed by physicians
Also known as: prenatal dietary supplement
maternal serum Calcium and Vitamin D concentrations
Evaluating using maternal blood samples to measure change in serum calcium levels in mg/dL And Vitamin D Levels in ng/mL from baseline to delivery.
Time frame: .Blood samples were collected at the 8th and 33rd weeks of gestation to assess changes in plasma calcium concentration through blood sampling, from enrollment to delivery .
Incidence of Fetomaternal Complications
Number of participants who experience fetomaternal complications including, Delayed fetal growth , Preeclamsia
Time frame: Throughout Pregnancy upto delivery
Plan to share: Undecided — It has not been determined whether individual participant data IPD will be shared. Any potential future sharing will depend on institutional review board IRB OR REC approval and participant privacy regulations.
Ran from Aug 2024 to primary completion in Jan 2025, 5 months.
Of 20 interventional studies with no phase under Hypocalcemia, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 39. This study's 5 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Lahore Hospital (ULH)